"The Brief Case: Erysipelothrix bacteremia and endocarditis in a 59-year-old immunocompromised male on chronic high-dose steroids
surgical intervention, but mild mitral regurgitation was noted. The open wound on the patient's right great toe was thought to be the source of infection, as the patient reported frequently walking barefoot at home and has pet cats and dogs. Drainage fluid from the ulcer was submitted for aerobic culture. Gram stain of the primary specimen demonstrated no inflammatory cells or organisms seen, and the culture grew rare mixed Gram-positive organisms. X-ray and magnetic resonance imaging of the right foot revealed soft tissue swelling and no evidence of osteomyelitis. The patient remained clinically asymptomatic and was discharged with 6 weeks of i.v. penicillin G. At 4 weeks postdischarge, the patient was readmitted with low-grade fevers and left upper extremity swelling consistent with deep vein thrombosis secondary to the peripherally inserted central catheter line. Posttreatment blood cultures remained negative, and follow-up TEE findings were unchanged compared with those of previous studies. The patient completed the remaining week of antimicrobial therapy with i.v. ceftriaxone and recovered with no further complications.
DISCUSSION
Erysipelothrix rhusiopathiae is a facultative anaerobic non-spore-forming Grampositive bacillus. First isolated by Koch in 1880, E. rhusiopathiae was identified as the causative agent of swine erysipelas and later recovered from a human patient with localized infection in 1909 (1) . E. rhusiopathiae is widely distributed but is most frequently associated with pigs and can also be found in the digestive tracts of various animals, including fish, sheep, and cattle, as well as dogs and cats. Two additional species in the genus, namely Erysipelothrix tonsillarum and Erysipelothrix inopinata, have been recovered from the tonsils of healthy pigs and cattle and the environment. Although a rare cause of human infection, E. rhusiopathiae enters the environment when shed in the urine or feces of infected animals and are transmitted to humans from direct contact through cuts, abrasions, and injuries.
E. rhusiopathiae is largely a zoonotic pathogen that can cause disease in a variety of animals. In pigs, E. rhusiopathiae can cause an acute infection characterized by septicemia and diffuse erythema resulting in sudden death. Subacute and chronic infections presenting as cutaneous lesions or local arthritis and endocarditis can also occur. In other animals, including sheep, cattle, and birds, E. rhusiopathiae can cause skin lesions and arthritis and can result in death (2) .
Human Erysipelothrix sp. infection is rare and is usually due to exposure to infected animals, such as fish or swine. As such, individuals with occupational exposures to animals or animal products, such as veterinarians, abattoir workers, and fisherman, are at greatest risk for infection (3) . Infections can manifest in one of the following three forms: (i) a localized cutaneous lesion or erysipeloid, (ii) a generalized cutaneous form, and (iii) a septicemic form which is often associated with infectious endocarditis. In the localized cutaneous form, the erysipeloid develops 2 to 4 days postexposure, and infection is typically limited to the fingers or hand. Surface swabs are not useful for isolation of E. rhusiopathiae from cutaneous lesions since the organisms reside deep in the subdermal layer. Rather, biopsy specimens are optimal for isolation of the organism. In bloodstream infections, E. rhusiopathiae can be recovered from standard blood cultures and is strongly associated with endocarditis. E. rhusiopathiae endocarditis occurs in patients with underlying heart conditions and animal exposure and can have mortality approaching 40% (1). Although as many as 90% of E. rhusiopathiae bloodstream infections are associated with endocarditis, newer reports suggest endocarditis due to systemic E. rhusiopathiae infection is rare (4). In the absence of occupational exposures, risk factors for invasive Erysipelothrix rhusiopathiae infection include immunocompromising conditions, such as chronic kidney disease, diabetes mellitus, and treatment with high-dose steroids (as was the case with this patient). In patients with E. rhusiopathiae endocarditis, excessive alcohol use, in addition to underlying heart conditions, has also been identified as a significant risk factor (1, 4) .
Identification of Erysipelothrix species can present some diagnostic challenges. The organism can have an uneven Gram stain appearance and may even appear Gram negative at times, similar to this case (Fig. 1A and B) . Colonies are pinpoint and alpha-hemolytic on routine medium, as shown in Fig. 1C , and the short Gram-positive rods can resemble streptococci and enterococci. Similar to enterococci, E. rhusiopathiae is also positive for pyrrolidonyl aminopeptidase (PYR) activity, which may contribute to misidentification. Erysipelothrix species can be differentiated from enterococci by the ability to produce hydrogen sulfide (H 2 S) on TSI Agar (Fig. 1E) . Biochemical testing and Gram stain appearance may readily distinguish Erysipelothrix sp. isolates from other non-spore-forming Gram-positive bacilli, including Corynebacterium spp., Listeria monocytogenes, and Lactobacillus spp. (Table 1 ). Positive catalase reactions differentiate Corynebacterium spp. and Listeria spp. from Erysipelothrix spp., which are negative for most rapid biochemical tests, including catalase, oxidase, indole, methyl red, VogesProskauer, and hydrolysis of esculin or urea (5) . Lactobacillus species are catalasenegative long, slender Gram-positive bacilli that can be vancomycin resistant and are also associated with bloodstream infection and endocarditis. However, Lactobacillus species are negative for H 2 S production on TSI Agar. Another unique characteristic of E. rhusiopathiae is the "bottle-brush" or "pipe cleaner" appearance of growth in a gelatin stab. Further biochemical testing is necessary for species-level differentiation of E. rhusiopathiae from E. tonsillarum, which ferments sucrose and is positive for alkaline phosphatase (5) .
Automated identification systems, including Vitek2 (bioMérieux, Durham, NC) and BD Phoenix (BD Diagnostics, Sparks, MD), as well as the API Coryne and Strep systems (bioMérieux, Durham, NC), can reliably identify E. rhusiopathiae. MALDI-TOF mass spectrometry can also identify E. rhusiopathiae. FDA-cleared databases for both Bruker biotyper CA and Vitek MS systems do not include Erysipelothrix species. However, the Bruker biotyper RUO database includes mass spectral profiles (MSP) for both E. rhusiopathiae and E. tonsillarum, while the Vitek MS KnowledgeBase RUO library only includes E. rhusiopathiae. While 16S rRNA sequencing has been used to identify Erysipelothrix species, the Ͼ99% sequence identity of the 16S rRNA gene between some Erysipelothrix species may preclude use of this method for species-level identification (2) .
Erysipelothrix spp. are intrinsically resistant to vancomycin; thus, prompt and accurate identification is critical to ensure effective antibiotic therapy. Ampicillin and penicillin are the treatment of choice for both localized and systemic Erysipelothrix infections, as resistance to these agents has not been described. Other beta-lactams, including extended-spectrum cephalosporins and carbapenems, have comparable in vitro activity against Erysipelothrix isolates. In penicillin-allergic patients, erythromycin, clindamycin, and fluoroquinolones can be considered. Although susceptibility testing is usually unnecessary, testing may be warranted for penicillin-allergic patients, as resistance to clindamycin and erythromycin has been noted. Antimicrobial susceptibility testing guidelines and interpretive breakpoints for Erysipelothrix rhusiopathiae are published in the M45 document from Clinical and Laboratory Standards Institute (CLSI) (6) . Treatment with aminoglycosides and sulfonamides is not recommended, as Erysipelothrix isolates are frequently resistant to these agents.
In summary, we present a case of Erysipelothrix rhusiopathiae bloodstream infection and endocarditis in a patient on chronic steroids due to rheumatoid arthritis. This isolate was identified using MALDI-TOF MS and confirmed with biochemical testing. Rapid and accurate identification of this isolate facilitated prompt initiation of appropriate antimicrobial therapy, which contributed to successful treatment and recovery of the patient. 
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